Research ArticleDrug Discovery and Translational Medicine
Open Access
TAS-303, a Novel Selective Norepinephrine Reuptake Inhibitor that Increases Urethral Pressure in Rats, Indicating Its Potential as a Therapeutic Agent for Stress Urinary Incontinence
Hiroya Mizutani, Fukumitsu Sakakibara, Masahito Komuro and Eiji Sasaki
Journal of Pharmacology and Experimental Therapeutics August 2018, 366 (2) 322-331; DOI: https://doi.org/10.1124/jpet.118.248039
Hiroya Mizutani
Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan
Fukumitsu Sakakibara
Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan
Masahito Komuro
Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan
Eiji Sasaki
Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
TAS-303, a Novel NRI, Increases Urethral Pressure in Rats
Hiroya Mizutani, Fukumitsu Sakakibara, Masahito Komuro and Eiji Sasaki
Journal of Pharmacology and Experimental Therapeutics August 1, 2018, 366 (2) 322-331; DOI: https://doi.org/10.1124/jpet.118.248039
Research ArticleDrug Discovery and Translational Medicine
TAS-303, a Novel NRI, Increases Urethral Pressure in Rats
Hiroya Mizutani, Fukumitsu Sakakibara, Masahito Komuro and Eiji Sasaki
Journal of Pharmacology and Experimental Therapeutics August 1, 2018, 366 (2) 322-331; DOI: https://doi.org/10.1124/jpet.118.248039
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement